Achieve Life Sciences, Inc. Operating Lease, Expense
Achieve Life Sciences, Inc. (ACHV) reported Operating Lease, Expense of $29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-11
- Achieve Life Sciences, Inc. operating lease, expense for the quarter ending 2026-06-30 was $29.00K, a 3.33% decline year-over-year.
- Achieve Life Sciences, Inc. operating lease, expense for the quarter ending 2026-03-31 was $32.00K, a 3.23% increase year-over-year.
- Achieve Life Sciences, Inc. operating lease, expense for the quarter ending 2025-12-31 was $0.00.
- Achieve Life Sciences, Inc. operating lease, expense for the quarter ending 2025-09-30 was $25.00K, a 13.79% decline year-over-year.
- Achieve Life Sciences, Inc. operating lease, expense for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
- Achieve Life Sciences, Inc. operating lease, expense for fiscal 2024 was $100.00K, a 0.00% change from fiscal 2023.
- Achieve Life Sciences, Inc. operating lease, expense for fiscal 2023 was $100.00K, a 0.00% change from fiscal 2022.
- Achieve Life Sciences, Inc. operating lease, expense for fiscal 2022 was $100.00K, a 0.00% change from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-11 | $61.00K 10-Q · filed 2026-08-11 | $61.00K derived: sum of 3 quarters · filed 2026-08-11 | $86.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $32.00K 10-Q · filed 2026-05-12 | $32.00K derived: sum of 2 quarters · filed 2026-05-12 | $57.00K derived: sum of 3 quarters · filed 2026-05-12 | $87.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $25.00K derived: sum of 2 quarters · filed 2026-03-24 | $55.00K derived: sum of 3 quarters · filed 2026-08-11 | $100.00K 10-K · filed 2026-03-24 | |
| 2025-09-30 | $25.00K 10-Q · filed 2025-11-06 | $55.00K derived: sum of 2 quarters · filed 2026-08-11 | $100.00K 10-Q · filed 2025-11-06 | $86.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $30.00K 10-Q · filed 2026-08-11 | $61.00K 10-Q · filed 2026-08-11 | $61.00K derived: sum of 3 quarters · filed 2026-08-11 | $90.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $31.00K 10-Q · filed 2026-05-12 | $31.00K derived: sum of 2 quarters · filed 2026-05-12 | $60.00K derived: sum of 3 quarters · filed 2026-05-12 | $89.00K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $29.00K derived: sum of 2 quarters · filed 2026-03-24 | $58.00K derived: sum of 3 quarters · filed 2026-03-24 | $100.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $29.00K 10-Q · filed 2025-11-06 | $58.00K derived: sum of 2 quarters · filed 2025-11-06 | $100.00K 10-Q · filed 2025-11-06 | $87.00K derived: sum of 4 quarters · filed 2026-03-24 | |
| 2024-06-30 | $29.00K 10-Q · filed 2025-08-07 | $58.00K 10-Q · filed 2025-08-07 | $58.00K derived: sum of 3 quarters · filed 2026-03-24 | $87.00K derived: sum of 4 quarters · filed 2026-03-24 | |
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-13 | $29.00K derived: sum of 2 quarters · filed 2026-03-24 | $58.00K derived: sum of 3 quarters · filed 2026-03-24 | $86.00K derived: sum of 4 quarters · filed 2026-03-24 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $29.00K derived: sum of 2 quarters · filed 2026-03-24 | $57.00K derived: sum of 3 quarters · filed 2026-03-24 | $100.00K 10-K · filed 2026-03-24 | |
| 2023-09-30 | $29.00K 10-Q · filed 2024-11-07 | $57.00K derived: sum of 2 quarters · filed 2024-11-07 | $100.00K 10-Q · filed 2024-11-07 | $86.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $28.00K 10-Q · filed 2024-08-13 | $57.00K 10-Q · filed 2024-08-13 | $57.00K derived: sum of 3 quarters · filed 2025-03-11 | $82.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $29.00K 10-Q · filed 2024-05-09 | $29.00K derived: sum of 2 quarters · filed 2025-03-11 | $54.00K derived: sum of 3 quarters · filed 2025-03-11 | $87.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $25.00K derived: sum of 2 quarters · filed 2025-03-11 | $58.00K derived: sum of 3 quarters · filed 2025-03-11 | $100.00K 10-K · filed 2025-03-11 | |
| 2022-09-30 | $25.00K 10-Q · filed 2023-11-09 | $58.00K derived: sum of 2 quarters · filed 2023-11-09 | $100.00K 10-Q · filed 2023-11-09 | $91.00K 10-Q · filed 2022-11-14 | $91.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $33.00K 10-Q · filed 2023-08-14 | $66.00K 10-Q · filed 2023-08-14 | $66.00K derived: sum of 3 quarters · filed 2024-03-28 | $95.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-03-31 | $33.00K 10-Q · filed 2023-05-09 | $33.00K derived: sum of 2 quarters · filed 2024-03-28 | $62.00K derived: sum of 3 quarters · filed 2024-03-28 | $162.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $29.00K derived: sum of 2 quarters · filed 2024-03-28 | $129.00K derived: sum of 3 quarters · filed 2024-03-28 | $100.00K 10-K · filed 2024-03-28 | |
| 2021-09-30 | $29.00K 10-Q · filed 2022-11-14 | $129.00K derived: sum of 2 quarters · filed 2022-11-14 | $100.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-11 | $100.00K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $42.00K 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $200.00K 10-K · filed 2023-03-16 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $100.00K derived: sum of 2 quarters · filed 2022-03-10 | $200.00K derived: sum of 3 quarters · filed 2022-03-10 | $200.00K 10-K · filed 2022-03-10 | |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-06 | $200.00K derived: sum of 2 quarters · filed 2019-11-06 | $200.00K 10-Q · filed 2019-11-06 | $400.00K derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-08 | $100.00K 10-Q · filed 2019-08-08 | $300.00K derived: sum of 3 quarters · filed 2021-03-11 | $400.00K derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-15 | $200.00K derived: sum of 2 quarters · filed 2021-03-11 | $300.00K derived: sum of 3 quarters · filed 2021-03-11 | $400.00K derived: sum of 4 quarters · filed 2021-03-11 | |
| 2018-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $200.00K derived: sum of 2 quarters · filed 2021-03-11 | $300.00K derived: sum of 3 quarters · filed 2021-03-11 | $300.00K 10-K · filed 2021-03-11 | |
| 2018-09-30 | $100.00K 10-Q · filed 2019-11-06 | $200.00K derived: sum of 2 quarters · filed 2019-11-06 | $200.00K 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $100.00K 10-Q · filed 2019-08-08 | $200.00K 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |